FDA approves first treatment for pediatric patients with lupus - FDA Press Releases

FDA approves Benlysta for treatment of children with systemic lupus erythematosus (SLE), a chronic disease causing inflammation and damage to tissue and organs

from FDA Press Releases RSS Feed http://bit.ly/2L6iCiQ
via IFTTT